160 related articles for article (PubMed ID: 1774347)
1. Cervical cancer rates by population size of towns: implications for cancer control programs.
Polednak AP; Flannery JT; Janerich DT
J Community Health; 1991 Dec; 16(6):315-23. PubMed ID: 1774347
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of cancer incidence in Connecticut counties and towns, 1989-91.
Polednak AP; Flannery JT
Conn Med; 1995 Jun; 59(6):323-30. PubMed ID: 7648850
[TBL] [Abstract][Full Text] [Related]
3. Uterine cervical carcinoma in Connecticut, 1935-1973: evidence for two classes of invasive disease.
Laskey PW; Meigs JW; Flannery JT
J Natl Cancer Inst; 1976 Nov; 57(5):1037-43. PubMed ID: 1003540
[TBL] [Abstract][Full Text] [Related]
4. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
5. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality.
Schootman M; Fuortes LJ
Cancer; 1999 Sep; 86(6):1087-94. PubMed ID: 10491538
[TBL] [Abstract][Full Text] [Related]
6. Geographic pattern of cancers related to tobacco and alcohol in Connecticut: implications for cancer control.
Polednak AP
Cancer Detect Prev; 2004; 28(4):302-8. PubMed ID: 15350634
[TBL] [Abstract][Full Text] [Related]
7. Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population.
Friedell GH; Tucker TC; McManmon E; Moser M; Hernandez C; Nadel M
J Natl Cancer Inst; 1992 Jul; 84(13):1030-2. PubMed ID: 1608055
[TBL] [Abstract][Full Text] [Related]
8. Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer.
Bergström R; Adami HO; Gustafsson L; Pontén J; Sparén P
J Natl Cancer Inst; 1993 Jul; 85(13):1050-7. PubMed ID: 8515491
[TBL] [Abstract][Full Text] [Related]
9. [Evidence for regression of carcinoma-in-situ and for a second form of invasive cervical cancer, Connecticut 1935-73].
Meigs JW; Laskey PW; Flannery JT
Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):554-69. PubMed ID: 955362
[No Abstract] [Full Text] [Related]
10. Estimating cervical cancer incidence in the Hispanic population of Connecticut by use of surnames.
Polednak AP
Cancer; 1993 Jun; 71(11):3560-4. PubMed ID: 8490904
[TBL] [Abstract][Full Text] [Related]
11. Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea.
Boo YK; Kim WC; Lee HY; Leem JH; Lee MH; Leem JS
Asian Pac J Cancer Prev; 2011; 12(8):1985-8. PubMed ID: 22292638
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and standardized incidence rates of preclinical cervical pathology among 1,061 women sterilized with transcervical quinacrine hydrochloride pellets.
Dabancens A; Sokal DC; Pruyas M; Rivera M; Zipper J
Fertil Steril; 1995 Aug; 64(2):444-6. PubMed ID: 7615128
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
14. Decline in the incidence of carcinoma in situ of the cervix.
Chow WH; Greenberg RS; Liff JM
Am J Public Health; 1986 Nov; 76(11):1322-4. PubMed ID: 3766828
[TBL] [Abstract][Full Text] [Related]
15. Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95.
Gregorio DI; Kulldorff M; Barry L; Samociuk H
Int J Cancer; 2002 Jul; 100(2):194-8. PubMed ID: 12115569
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).
Melan K; Janky E; Macni J; Ulric-Gervaise S; Dorival MJ; Veronique-Baudin J; Joachim C
Glob Health Action; 2017; 10(1):1337341. PubMed ID: 28649938
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pre-invasive conditions during opportunistic screening and its effectiveness on cervical cancer incidence in one Norwegian county.
Forsmo S; Buhaug H; Skjeldestad FE; Haugen OA
Int J Cancer; 1997 Mar; 71(1):4-8. PubMed ID: 9096657
[TBL] [Abstract][Full Text] [Related]
18. [Cervical smears in women under 30 years age (author's transl)].
Dartsch W; Freundl G; Massenkeil HJ
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):849-52. PubMed ID: 700345
[TBL] [Abstract][Full Text] [Related]
19. Trends in cervical cancer and carcinoma in situ in Great Britain.
Cook GA; Draper GJ
Br J Cancer; 1984 Sep; 50(3):367-75. PubMed ID: 6466546
[TBL] [Abstract][Full Text] [Related]
20. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
van Oortmarssen GJ; Habbema JD
Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
